Back to News
Market Impact: 0.18

OSPN vs. ADYEY: Which Stock Is the Better Value Option?

Company FundamentalsAnalyst EstimatesAnalyst InsightsCorporate Earnings
OSPN vs. ADYEY: Which Stock Is the Better Value Option?

OneSpan appears better positioned than Adyen on valuation and earnings outlook, with a Zacks Rank of #2 versus #3 for Adyen. OneSpan trades at a lower forward P/E of 11.51 versus 21.38 for Adyen, with a PEG of 1.05 and P/B of 1.93 compared with Adyen's 1.29 PEG and 5.63 P/B. The article concludes OneSpan is the superior value option, though the piece is primarily comparative commentary and is unlikely to materially move either stock.

Analysis

The market is being told this is a simple relative-value call, but the more important signal is that OSPN’s multiple is already pricing in a far more fragile earnings path than the revision trend implies. When a small-cap software name screens this cheaply on forward earnings and book value while estimates are turning up, the setup is usually less about rerating to a premium and more about mean reversion in the sell-side’s terminal growth assumptions. That can create a fast, mechanically driven move because value screens and quant factors will often chase the same names once the revisions trend holds for another quarter.

Second-order, the real winner may be not OSPN’s product moat but its capital structure flexibility: a cheaper equity currency gives management more room to do tuck-in M&A, buybacks, or absorb transient margin pressure without the market immediately punishing them. By contrast, the richer multiple in ADYEY leaves much less room for disappointment if transaction volumes, take rates, or Europe/enterprise spend normalize; any deceleration would likely compress the stock disproportionately because investors are paying for durable compounding rather than cyclical recovery. In that sense, this is less a “who has the better business” call than a “whose expectations are more vulnerable” call.

The key risk to the long OSPN thesis is that estimate revisions are often lagging, not leading. If management commentary in the next 1-2 quarters shows that current-year upside is being pulled forward from lower-quality items like expense timing or one-off mix, the valuation gap can stay cheap or even widen. The contrarian read is that the market may be correctly distinguishing between a value trap and a quality compounder: OSPN may be optically cheap because its long-term growth ceiling is structurally lower, while ADYEY’s premium may be justified if its unit economics remain best-in-class.

More News